FDA PMA FDA Class 3 Approved 🇺🇸 United States

Kit, Dna Detection, Human Papillomavirus

PMA: P160037 · Supplement: S020 · Decision Nov 5, 2024
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Kit, Dna Detection, Human Papillomavirus
Trade Name
BD Onclarity™ HPV Assay
PMA Number
P160037
Supplement Number
S020
Device Class
FDA Class 3
Product Code
MAQ
Generic Name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
November 5, 2024
Date Received
May 10, 2024
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for changes to the BD Pre-warm Heater which is used with the BD Viper LT System to perform the BD Onclarity HPV Assay.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAQ Kit, Dna Detection, Human Papillomavirus